Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transaction

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash deal. This strategic move aims to bolster Sun Pharma's product offerings. Innovcare, which markets pharmaceutical drugs, nutraceuticals, and cosmeceuticals, reported steady revenue growth in recent fiscal years. The transaction, expected to conclude by July 2026, is a significant step for Sun Pharma's expansion.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/x6BPKQN
via IFTTT

Read More

Yoga may boost cognition, reduce depression, aid gut health in early Alzheimer's: AIIMS study

A 12-week yoga program has shown promising results for individuals with mild Alzheimer's disease. Researchers at AIIMS, Delhi, observed significant improvements in cognitive function and mood, alongside a healthier gut microbiome. The study suggests yoga may help restore beneficial gut bacteria, potentially influencing the gut-brain axis and offering a valuable complementary therapy for early-stage Alzheimer's and mild cognitive impairment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xbKZrwE
via IFTTT

Read More

Plan in the works to let hospitals import med equipment directly

India's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing current import licenses. This move aims to speed up access to cutting-edge technology. However, the domestic medical device industry expresses concern, citing safety risks and the specialized expertise of licensed importers in handling high-risk equipment and ensuring quality.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iPEWgbe
via IFTTT

Read More

Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr

Global investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a 3 percent stake in Anthem Biosciences. The deal, valued at Rs 1,275 crore, saw promoter Aruna Ganesh exit the company. This significant transaction reshapes the promoter's holding in the integrated Contract Research, Development and Manufacturing Organisation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/67R3r9I
via IFTTT

Read More

Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon

Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federal Trade Commission for its takeover of Lannett Company. This regulatory approval removes the final hurdle. The acquisition is expected to close by the end of June.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XzE6rDb
via IFTTT

Read More

HPV vaccination drive reaches 50 lakh girls in three months

India's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine have been administered to 14-year-old girls. This initiative covers almost half of the 1.15 crore target population nationwide. Madhya Pradesh and Gujarat have already achieved 100% of their targets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/85l3uED
via IFTTT

Read More

US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisition

The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a condition for Aurobindo Pharma to finalize its acquisition of Lannett Company Inc., ensuring no anti-competitive issues arise from the deal.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/u3jUDq4
via IFTTT

Read More